Annual report pursuant to Section 13 and 15(d)

Bionik Laboratories Corp. (f/k/a Drywave Technologies, Inc.) - Consolidated Balance Sheets (Parantheticals)(USD $)

v2.4.1.9
Bionik Laboratories Corp. (f/k/a Drywave Technologies, Inc.) - Consolidated Balance Sheets (Parantheticals)(USD $) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Statement of Financial Position    
Preferred stock, par value (in dollars per share) $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare
Preferred stock, shares authorized 10,000,000us-gaap_PreferredStockSharesAuthorized 10,000,000us-gaap_PreferredStockSharesAuthorized
Preferred stock, shares issued 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued
Preferred stock, shares outstanding 0us-gaap_PreferredStockSharesOutstanding 0us-gaap_PreferredStockSharesOutstanding
Common stock, par value (in dollars per share) $ 0.001us-gaap_CommonStockParOrStatedValuePerShare $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
Common stock, shares authorized 150,000,000us-gaap_CommonStockSharesAuthorized 150,000,000us-gaap_CommonStockSharesAuthorized
Common stock, shares issued 96,589,680us-gaap_CommonStockSharesIssued 96,589,680us-gaap_CommonStockSharesIssued
Common stock, shares outstanding 96,589,680us-gaap_CommonStockSharesOutstanding 96,589,680us-gaap_CommonStockSharesOutstanding